{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T14:17:41Z","timestamp":1778249861018,"version":"3.51.4"},"reference-count":33,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T00:00:00Z","timestamp":1621209600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJERPH"],"abstract":"<jats:p>Certain underlying diseases such as diabetic mellitus and hypertension are a risk factor for the severity and mortality of coronavirus disease (COVID-19) patients. Furthermore, both angiotensin converting enzyme inhibitors (ACEi) and angiotensin II receptor blockers (ARBs) are controversial at role in the process of COVID-19 cases. The aim of the study was to investigate whether underlying diseases and taking ACEi\/ARBs, affect the duration of hospitalization and mortality in patients with confirmed COVID-19. Medical usage claims data for the past three years until 15 May 2020, from the \u201cCORONA-19 International Cooperation Research\u201d project was used. We analyzed the medical insurance claims data for all 7590 coronavirus (COVID-19) patients confirmed by RT-PCR tests nationwide up to 15 May 2020. Among the comorbidities, a history of hypertension (hazard ratio [HR], 1.51; 95% confidence interval [CI], 1.056\u20132.158) and diabetes (HR, 1.867; 95% CI, 1.408\u20132.475) were associated significantly with mortality. Furthermore, heart failure (HR, 1.391; 95% CI, 1.027\u20131.884), chronic obstructive pulmonary disease (HR, 1.615; 95% CI, 1.185\u20132.202), chronic kidney disease (HR, 1.451; 95% CI, 1.018\u20132.069), mental disorder (HR, 1.61; 95% CI, 1.106\u20132.343), end stage renal disease (HR, 5.353; 95% CI, 2.185\u201313.12) were also associated significantly with mortality. The underlying disease has increased the risk of mortality in patients with COVID-19. Diabetes, hypertension, cancer, chronic kidney disease, heart failure, and mental disorders increased mortality. Controversial whether taking ACEi\/ARBs would benefit COVID-19 patients, in our study, patients taking ACEi\/ARBs had a higher risk of mortality.<\/jats:p>","DOI":"10.3390\/ijerph18105342","type":"journal-article","created":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T12:19:57Z","timestamp":1621253997000},"page":"5342","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Evaluation of the Prognosis of COVID-19 Patients According to the Presence of Underlying Diseases and Drug Treatment"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6293-785X","authenticated-orcid":false,"given":"Ejin","family":"Kim","sequence":"first","affiliation":[{"name":"Department of Public Health Sciences, Institute of Health and Environment and Graduate School of Public Health, Seoul National University, Seoul 08826, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3215-8681","authenticated-orcid":false,"given":"Yong Chul","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Seoul National University Hospital, Seoul 03080, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae Yoon","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Dongguk University Ilsan Hospital, Goyang-si 10326, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiyun","family":"Jung","sequence":"additional","affiliation":[{"name":"Data management and Statistics Institute, Dongguk University Ilsan Hospital, Goyang-si 10326, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung Pyo","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Seoul National University College of Medicine, Seoul 03080, Korea"},{"name":"Kidney Research Institute, Seoul National University Hospital, Seoul 03080, Korea"},{"name":"Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul 07061, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7472-3752","authenticated-orcid":false,"given":"Ho","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Public Health Sciences, Institute of Health and Environment and Graduate School of Public Health, Seoul National University, Seoul 08826, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,5,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e209","DOI":"10.3346\/jkms.2020.35.e209","article-title":"Prognostic Factors for Severe Coronavirus Disease 2019 in Daegu, Korea","volume":"35","author":"Jang","year":"2020","journal-title":"J. Korean Med. Sci."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"CDC COVID-19 Response Team, Chow, N., Fleming-Dutra, K., Gierke, R., Hall, A., Hughes, M., Pilishvili, T., Ritchey, M., Ritchey, K., and Skoff, T. (2020). Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019\u2014United States, February 12\u2013March 28, 2020. Morb. Mortal. Wkly. Rep., 69, 382.","DOI":"10.15585\/mmwr.mm6913e2"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.diabet.2020.05.008","article-title":"Prognostic factors in patients with diabetes hospitalized for COVID-19: Findings from the CORONADO study and other recent reports","volume":"46","author":"Scheen","year":"2020","journal-title":"Diabetes Metab."},{"key":"ref_4","first-page":"1","article-title":"Clinical Characteristics and Disease Progression in Early-Stage COVID-19 Patients in South Korea: The Retrospective Cohort Study","volume":"9","author":"Choi","year":"2020","journal-title":"SSRN Electron. J."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1590\/s1678-9946202062045","article-title":"Chronic heart diseases as the most prevalent comorbidities among deaths by COVID-19 in Brazil","volume":"62","author":"Pachiega","year":"2020","journal-title":"Rev. Inst. Med. Trop. S\u00e3o Paulo"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1007\/s11255-020-02451-9","article-title":"Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection","volume":"52","author":"Henry","year":"2020","journal-title":"Int. Urol. Nephrol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.annepidem.2020.08.005","article-title":"Clinical characteristics and risk factors for mortality of patients with COVID-19 in a large data set from Mexico","volume":"52","year":"2020","journal-title":"Ann. Epidemiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1530\/EJE-20-0541","article-title":"How important is obesity as a risk factor for respiratory failure, intensive care admission and death in hospitalised COVID-19 patients? Results from a single Italian centre","volume":"183","author":"Rottoli","year":"2020","journal-title":"Eur. J. Endocrinol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13098-020-00565-9","article-title":"Risk and predictors of in-hospital mortality from COVID-19 in patients with diabetes and cardiovascular disease","volume":"12","author":"Rastad","year":"2020","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Hoffmann, M., Kleine-Weber, H., Kr\u00fcger, N., Mueller, M.A., Drosten, C., and P\u00f6hlmann, S. (2020). The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells. BioRxiv.","DOI":"10.1101\/2020.01.31.929042"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1161\/CIRCULATIONAHA.104.510461","article-title":"Effect of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Receptor Blockers on Cardiac Angiotensin-Converting Enzyme 2","volume":"111","author":"Ferrario","year":"2005","journal-title":"Circulation"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e016509","DOI":"10.1161\/JAHA.120.016509","article-title":"Coronavirus Disease 2019 (COVID-19): Do Angiotensin-Converting Enzyme Inhibitors\/Angiotensin Receptor Blockers Have a Biphasic Effect?","volume":"9","author":"Sommerstein","year":"2020","journal-title":"J. Am. Hear. Assoc."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/s41430-020-0652-1","article-title":"Diabetes and COVID-19: Evidence, current status and unanswered research questions","volume":"74","author":"Gupta","year":"2020","journal-title":"Eur. J. Clin. Nutr."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.2337\/dc20-1192","article-title":"Diabetes and COVID-19: Risks, Management, and Learnings from Other National Disasters","volume":"43","author":"Morris","year":"2020","journal-title":"Diabetes Care"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"108292","DOI":"10.1016\/j.diabres.2020.108292","article-title":"Diabetes and COVID 19 in South-East Asia","volume":"166","author":"Joshi","year":"2020","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.numecd.2020.05.014","article-title":"Diabetes as a risk factor for greater COVID-19 severity and in-hospital death: A meta-analysis of observational studies","volume":"30","author":"Mantovani","year":"2020","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Carrillo-Vega, M.F., Salinas-Escudero, G., Garc\u00eda-Pe\u00f1a, C., Guti\u00e9rrez-Robledo, L.M., and Parra-Rodr\u00edguez, L. (2020). Early estimation of the risk factors for hospitalization and mortality by COVID-19 in Mexico. PLoS ONE, 15.","DOI":"10.1101\/2020.05.11.20098145"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1002\/jmv.26424","article-title":"Epidemiology of COVID-19: A systematic review and meta-analysis of clinical characteristics, risk factors, and outcomes","volume":"93","author":"Li","year":"2021","journal-title":"J. Med. Virol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding Algorithms for Defining Comorbidities in ICD-9-CM and ICD-10 Administrative Data","volume":"43","author":"Quan","year":"2005","journal-title":"Med. Care"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3961\/jpmph.2010.43.1.42","article-title":"Comparative study on three algorithms of the ICD-10 Charlson comorbidity index with myocardial infarction patients","volume":"43","author":"Kim","year":"2010","journal-title":"J. Prev. Med. Public Health"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"m1985","DOI":"10.1136\/bmj.m1985","article-title":"Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: Prospective observational cohort study","volume":"369","author":"Docherty","year":"2020","journal-title":"BMJ"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Iftimie, S., L\u00f3pez-Azcona, A.F., Vicente-Miralles, M., Descarrega-Reina, R., Hern\u00e1ndez-Aguilera, A., Riu, F., Sim\u00f3, J.M., Garrido, P., Joven, J., and Camps, J. (2020). Risk factors associated with mortality in hospitalized patients with SARS-CoV-2 infection. A prospective, longitudinal, unicenter study in Reus, Spain. PLoS ONE, 15.","DOI":"10.1101\/2020.05.29.122986"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1001\/jama.2020.6130","article-title":"Association of Public Health Interventions with the Epidemiology of the COVID-19 Outbreak in Wuhan, China","volume":"323","author":"Pan","year":"2020","journal-title":"JAMA"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40249-020-00710-6","article-title":"Clinical characteristics of different subtypes and risk factors for the severity of illness in patients with COVID-19 in Zhejiang, China","volume":"9","author":"Zhang","year":"2020","journal-title":"Infect. Dis. Poverty"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.amepre.2020.05.002","article-title":"Clinical Characteristics, Associated Factors, and Predicting COVID-19 Mortality Risk: A Retrospective Study in Wuhan, China","volume":"59","author":"Yu","year":"2020","journal-title":"Am. J. Prev. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ijid.2020.04.041","article-title":"Clinical value of immune-inflammatory parameters to assess the severity of coronavirus disease 2019","volume":"95","author":"Zhu","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1001\/jamainternmed.2020.3539","article-title":"Risk factors associated with mortality among patients with COVID-19 in intensive care units in Lombardy, Italy","volume":"180","author":"Grasselli","year":"2020","journal-title":"JAMA Intern. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"100088","DOI":"10.1016\/j.lanwpc.2020.100088","article-title":"Power of universal health coverage in the era of COVID-19: A nationwide observational study","volume":"7","author":"Lee","year":"2021","journal-title":"Lancet Reg. Heal. West. Pac."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Alqahtani, J.S., Oyelade, T., Aldhahir, A.M., Alghamdi, S.M., Almehmadi, M., Alqahtani, A.S., Quaderi, S., Mandal, S., and Hurst, J.R. (2020). Prevalence, Severity and Mortality associated with COPD and Smoking in patients with COVID-19: A Rapid Systematic Review and Meta-Analysis. PLoS ONE, 15.","DOI":"10.1101\/2020.03.25.20043745"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"104927","DOI":"10.1016\/j.phrs.2020.104927","article-title":"ACEI\/ARB use and risk of infection or severity or mortality of COVID-19: A systematic review and meta-analysis","volume":"158","author":"Zhang","year":"2020","journal-title":"Pharmacol. Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.cell.2020.03.045","article-title":"Structural and functional basis of SARS-CoV-2 entry by using human ACE2","volume":"181","author":"Wang","year":"2020","journal-title":"Cell"},{"key":"ref_32","first-page":"m810","article-title":"Preventing a COVID-19 pandemic: ACE inhibitors as a potential risk factor for fatal COVID-19","volume":"368","author":"Sommerstein","year":"2020","journal-title":"BMJ"},{"key":"ref_33","first-page":"1769","article-title":"COVID-19 and angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: What is the evidence","volume":"323","author":"Patel","year":"2020","journal-title":"JAMA"}],"container-title":["International Journal of Environmental Research and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-4601\/18\/10\/5342\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:02:51Z","timestamp":1760162571000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-4601\/18\/10\/5342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,17]]},"references-count":33,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,5]]}},"alternative-id":["ijerph18105342"],"URL":"https:\/\/doi.org\/10.3390\/ijerph18105342","relation":{},"ISSN":["1660-4601"],"issn-type":[{"value":"1660-4601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,17]]}}}